001     144418
005     20240229123018.0
024 7 _ |a 10.1002/ijc.32576
|2 doi
024 7 _ |a pmid:31319002
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:63771407
|2 altmetric
037 _ _ |a DKFZ-2019-01871
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Christakoudi, Sofia
|0 0000-0001-9219-4436
|b 0
245 _ _ |a Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and Nutrition.
260 _ _ |a Bognor Regis
|c 2020
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1587465734_19055
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2020 May 15;146(10):2680-2693
520 _ _ |a Several studies have reported associations of hypertension with cancer, but not all results were conclusive. We examined the association of systolic (SBP) and diastolic (DBP) blood pressure with the development of incident cancer at all anatomical sites in the European Prospective Investigation into Cancer and Nutrition (EPIC). Hazard ratios (HR) (95% confidence intervals) were estimated using multivariable Cox proportional hazards models, stratified by EPIC-participating centre and age at recruitment, and adjusted for sex, education, smoking, body mass index, physical activity, diabetes and dietary (in women also reproductive) factors. The study included 307,318 men and women, with an average follow-up of 13.7 (standard deviation 4.4) years and 39,298 incident cancers. We confirmed the expected positive association with renal cell carcinoma: HR=1.12 (1.08-1.17) per 10mmHg higher SBP and HR=1.23 (1.14-1.32) for DBP. We additionally found positive associations for esophageal squamous cell carcinoma (SCC): HR=1.16 (1.07-1.26) (SBP), HR=1.31 (1.13-1.51) (DBP), weaker for head and neck cancers: HR=1.08 (1.04-1.12) (SBP), HR=1.09 (1.01-1.17) (DBP) and, similarly, for skin SCC, colon cancer, post-menopausal breast cancer and uterine adenocarcinoma (AC), but not for esophageal AC, lung SCC, lung AC, or uterine endometroid cancer. We observed weak inverse associations of SBP with cervical SCC: HR=0.91 (0.82-1.00) and lymphomas: HR=0.97 (0.93-1.00). There were no consistent associations with cancers in other locations. Our results are largely compatible with published studies and support weak associations of blood pressure with cancers in specific locations and morphologies. This article is protected by copyright. All rights reserved.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Kakourou, Artemisia
|b 1
700 1 _ |a Markozannes, Georgios
|b 2
700 1 _ |a Tzoulaki, Ioanna
|b 3
700 1 _ |a Weiderpass, Elisabete
|b 4
700 1 _ |a Brennan, Paul
|b 5
700 1 _ |a Gunter, Marc
|b 6
700 1 _ |a Dahm, Christina C
|b 7
700 1 _ |a Overvad, Kim
|b 8
700 1 _ |a Olsen, Anja
|b 9
700 1 _ |a Tjønneland, Anne
|b 10
700 1 _ |a Boutron-Ruault, Marie-Christine
|0 0000-0002-5956-5693
|b 11
700 1 _ |a Madika, Anne-Laure
|b 12
700 1 _ |a Severi, Gianluca
|b 13
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 14
|u dkfz
700 1 _ |a Kühn, Tilman
|0 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe
|b 15
|u dkfz
700 1 _ |a Bergmann, Manuela M
|b 16
700 1 _ |a Boeing, Heiner
|b 17
700 1 _ |a Karakatsani, Anna
|b 18
700 1 _ |a Martimianaki, Georgia
|b 19
700 1 _ |a Thriskos, Paschalis
|b 20
700 1 _ |a Masala, Giovanna
|b 21
700 1 _ |a Sieri, Sabina
|0 0000-0001-5201-172X
|b 22
700 1 _ |a Panico, Salvatore
|b 23
700 1 _ |a Tumino, Rosario
|b 24
700 1 _ |a Ricceri, Fulvio
|0 0000-0001-8749-9737
|b 25
700 1 _ |a Agudo, Antonio
|b 26
700 1 _ |a Redondo-Sánchez, Daniel
|b 27
700 1 _ |a Colorado-Yohar, Sandra M
|b 28
700 1 _ |a Mokoroa, Olatz
|b 29
700 1 _ |a Melander, Olle
|b 30
700 1 _ |a Stocks, Tanja
|b 31
700 1 _ |a Häggström, Christel
|0 0000-0001-6808-4405
|b 32
700 1 _ |a Harlid, Sophia
|b 33
700 1 _ |a Bueno-de-Mesquita, Bas
|b 34
700 1 _ |a van Gils, Carla H
|b 35
700 1 _ |a Vermeulen, Roel C H
|b 36
700 1 _ |a Khaw, Kay-Tee
|b 37
700 1 _ |a Wareham, Nicholas J
|b 38
700 1 _ |a Tong, Tammy Y N
|b 39
700 1 _ |a Freisling, Heinz
|b 40
700 1 _ |a Johansson, Mattias
|b 41
700 1 _ |a Lennon, Hannah
|b 42
700 1 _ |a Aune, Dagfinn
|b 43
700 1 _ |a Riboli, Elio
|b 44
700 1 _ |a Trichopoulos, Dimitrios
|b 45
700 1 _ |a Trichopoulou, Antonia
|b 46
700 1 _ |a Tsilidis, Konstantinos K
|b 47
773 _ _ |a 10.1002/ijc.32576
|g p. ijc.32576
|0 PERI:(DE-600)1474822-8
|n 10
|p 2680-2693
|t International journal of cancer
|v 146
|y 2020
|x 1097-0215
909 C O |o oai:inrepo02.dkfz.de:144418
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J CANCER : 2017
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21